RankingsPricing
  1. JP-listed companies
  2. Fuso Pharmaceutical Industries,Ltd.
  3. Financials
  4. Net income

Fuso Pharmaceutical Industries,Ltd.【JP:4538】

Market cap
¥22.4B
P/E ratio
8.8x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Mar 31, 2025-3,288-338.78%
Mar 31, 20241,377-14.21%
Mar 31, 20231,605+8.23%
Mar 31, 20221,483-7.72%
Mar 31, 20211,607+127.30%
Mar 31, 2020707-20.92%
Mar 31, 2019894-7.84%
Mar 31, 2018970+12.66%
Mar 31, 2017861+8510.00%
Mar 31, 201610-97.06%
Mar 31, 2015340-82.82%
Mar 31, 20141,979-59.37%
Mar 31, 20134,871+1731.20%
Mar 31, 2012266

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)